from common-pcom:html:key:en_segment_includes_overall_segment_header_shtml
PR Newswire: news distribution, targeting and monitoring
Home Page > News Releases > Global

WuXi PharmaTech Listed Among Asia’s Fastest Growing Companies,Third Year Running

2006-12-14 18:52

SHANGHAI, China, Dec. 14 /Xinhua-PRNewswire/ -- WuXi PharmaTech, China’s

leading provider of pharmaceutical R&D outsourcing services announced today

that it has been named 173rd on the Deloitte Technology Fast 500 Asia Pacific

2006 ranking. This is the third consecutive year the pharmaceutical service

company has received the prestigious award, placing it in an elite group of

only 58 companies.

(Logo: )

The Deloitte Touche Tohmatsu (Deloitte) Technology Fast 500 Asia Pacific

award is Asia’s most objective industry-ranking standard, focusing

specifically on the technology sector. The award was first introduced in

2001 to recognize the most exceptional of Asia’s 500 fastest-growing

technology companies from industries including all areas of technology,

ranging form internet based companies to biotechnology. The 2006 list, like

years prior, is a mixture of both public and private companies.

This year’s 173rd ranking represents a 244% 3-year annual growth rate

for the pharmaceutical service company. WuXi PharmaTech is among only 58

companies to be recognized for a third consecutive year.

“We are honored to have our success once again recognized,” commented

Dr. Ge Li, Chairman and CEO of WuXi PharmaTech. “It is a great

encouragement and satisfaction to be listed alongside prominent companies

such as Infosys of India and others who have been selected for a third

consecutive year. This designation reflects highly on WuXi PharmaTech’s

commitment to quality of service, high operating standards, and

transparency,” continued Dr. Li.

About WuXi PharmaTech

Founded in 2001, Shanghai-based WuXi PharmaTech is China’s leading drug

R&D service company. As a research-driven and customer-focused company, WuXi

PharmaTech offers global pharmaceutical and biopharmaceutical companies a

diverse, value-added, and fully integrated portfolio of outsourcing services

ranging from discovery chemistry, service biology to bioanalytical chemistry,

from process chemistry to large scale GMP manufacturing. WuXi PharmaTech

assists its global partners in shorting the cycle and lowering the cost of

drug discovery and development by providing cost-effective and efficient

outsourcing solutions that save our clients both time and money. Currently,

our client list consists of 19 of the top 20 pharmaceutical, and 8 of the top

10 biopharmaceutical companies. For more information please visit .

About Deloitte

Deloitte refers to one or more of Deloitte Touche Tohmatsu, a Swiss

Verein, its member firms, and their respective subsidiaries and affiliates.

Deloitte Touche Tohmatsu is an organization of member firms around the world

devoted to excellence in providing professional services and advice, focused

on client service through a global strategy executed locally in nearly 150

countries. With access to the deep intellectual capital of 135,000 people

worldwide, Deloitte delivers services in four professional areas-audit, tax,

consulting, and financial advisory services-and serves more than one-half of

the world’s largest companies, as well as large national enterprises, public

institutions, locally important clients, and successful, fast-growing global

growth companies. For more information please visit .

Source: WuXi PharmaTech Co., Ltd.

Related stocks: NYSE:WX

from common-pcom:html:key:en_segment_includes_releases_right_column_video_module_shtml

Featured Video

Related Keywords:


from common-pcom:html:key:en_segment_includes_overall_segment_footer_shtml
Advanced Search
  1. Products & Services
  2. News Releases
  3. Knowledge Center
  4. Journalists & Media
  5. Multimedia Theater
  6. Contact Us